Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
about
Deciphering the divergent roles of progestogens in breast cancer.Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programsInterferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer.Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.Estrogens regulate life and death in mitochondria.Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.DNA Sequence Constraints Define Functionally Active Steroid Nuclear Receptor Binding Sites in Chromatin.Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.Chromatin reprogramming in breast cancer.Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report.Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer.A patient-derived explant (PDE) model of hormone-dependent cancer
P2860
Q30240711-2C354372-4F93-4FDF-80F6-C4EBE9641EB9Q33568421-D1FC7E39-7D67-4BB4-98D9-5AAD11A9D3CBQ38697912-5ABE8FC4-7201-4757-ADBC-14A6D2C7628DQ38735015-716BD322-E370-4FF0-8089-390ACA345A86Q38855662-3D7AF6F6-62DE-488C-9C45-0AA0CC26D6D2Q39005392-0498AD53-3675-41C9-977B-D3C7B23CB09EQ39236899-04CEF6B2-CF67-4706-A927-C973B1D101E8Q39262264-236A062C-C189-4001-BA9A-292C4C0A48D2Q47101494-9198EA66-E665-457F-A06A-74CF707D1ED5Q47217714-49703D0F-BC64-4CCD-AD0A-E1C24153552FQ47699717-D39AB173-E8CE-48AA-966A-430F4871D756Q50053097-F43E0C51-8274-474D-B4BB-294A8970D7BAQ50879143-5A6B1B36-1D17-452F-B88D-37017E6917D8Q52310380-7064EE59-BD93-435C-B93D-A8551A4637A2Q52594020-3104D22B-5CD0-4628-9B77-C296B0B59D96Q55423955-5FF1A890-89A2-4334-9C4B-45E41DFE19B2Q58772979-5CCEC6D4-E684-49A6-80E4-4F41712B5BC7
P2860
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@en
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@nl
type
label
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@en
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@nl
prefLabel
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@en
Genomic agonism and phenotypic ...... ne receptors in breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genomic agonism and phenotypic ...... one receptors in breast cancer
@en
P2093
Ganesh V Raj
Geoffrey L Greene
Hari Singhal
Muriel Laine
Ryan J Bourgo
Shihong Ma
Ya-Fang Chang
P2860
P304
P356
10.1126/SCIADV.1501924
P577
2016-06-24T00:00:00Z